Effects of steroids on thrombogenic markers in patients undergoing unilateral total knee arthroplasty: a prospective, double-blind, randomized controlled trial. 2015

Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
Department of Orthopaedic Surgery, Hospital for Special Surgery, 535 E 70th Street, NY, 10021, New York.

Venous thromboembolism (VTE) remains an important complication after total knee arthroplasty (TKA). Systemic thrombin generation starts perioperatively. Inflammation, characterized by a rise in interleukin-6 (IL6), initiates the coagulation cascade, but low-dose steroids can reduce post-TKA IL6 levels. This double-blinded, randomized, placebo-controlled study enrolled 30 patients undergoing unilateral TKA to assess the effect of perioperative steroids on serum prothrombin fragment (PF1.2), a marker of thrombin generation, and plasmin-alpha-2-antiplasmin complex (PAP), a marker of fibrinolysis. Study patients received 100 mg of intravenous hydrocortisone 2 h prior to surgery, and controls received normal saline. Blood samples, drawn pre-incision and at 4 h post tourniquet release, were assayed for PF1.2 and PAP. The study group had significantly lower mean PF1.2 at 4 h compared to controls (616 ± 358 pMol/L vs. 936 ± 332 pMol/L, p = 0.037). The mean rise in PF1.2 in the control group was significantly greater compared to the study group (672 ± 173 pMol/L vs. 350 ± 211 pMol/L, p < 0.001). Mean PAP was higher in the study group at 4 h (1639 ± 823 µg/L vs. 1087 ± 536 µg/L), but did not reach statistical significance (p = 0.07). These results may have clinical implications in terms of postoperative VTE risk and management.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011516 Prothrombin A plasma protein that is the inactive precursor of thrombin. It is converted to thrombin by a prothrombin activator complex consisting of factor Xa, factor V, phospholipid, and calcium ions. Deficiency of prothrombin leads to hypoprothrombinemia. Coagulation Factor II,Factor II,Blood Coagulation Factor II,Differentiation Reversal Factor,Factor II, Coagulation,Factor, Differentiation Reversal,II, Coagulation Factor
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D005341 Fibrinolysin A product of the lysis of plasminogen (profibrinolysin) by PLASMINOGEN activators. It is composed of two polypeptide chains, light (B) and heavy (A), with a molecular weight of 75,000. It is the major proteolytic enzyme involved in blood clot retraction or the lysis of fibrin and quickly inactivated by antiplasmins. Plasmin,Fibrogammin,Glu-Plasmin,Protease F,Thrombolysin,Glu Plasmin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
January 2023, Frontiers in neurology,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
December 2020, International orthopaedics,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
April 2023, Journal of orthopaedic surgery and research,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
June 2016, Pain and therapy,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
June 2021, International orthopaedics,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
October 2017, The Journal of arthroplasty,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
January 2013, Therapeutics and clinical risk management,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
March 2022, BMC musculoskeletal disorders,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
January 2024, Drug design, development and therapy,
Alexander S McLawhorn, and Jonathan Beathe, and Jacques YaDeau, and Valeria Buschiazzo, and P Edward Purdue, and Yan Ma, and Thomas P Sculco, and Kethy Jules-Elysée
February 2024, The Journal of arthroplasty,
Copied contents to your clipboard!